Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02687139 |
Recruitment Status :
Completed
First Posted : February 22, 2016
Results First Posted : April 29, 2020
Last Update Posted : April 29, 2020
|
Sponsor:
Johns Hopkins University
Information provided by (Responsible Party):
Johns Hopkins University
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: N/A; Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Diagnostic |
Conditions |
Renal Cell Carcinoma Kidney Cancer |
Interventions |
Drug: 18F-DCFPyL Procedure: PET/CT |
Enrollment | 34 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | 18F-DCFPyL PET/CT |
---|---|
![]() |
18F-DCFPyL PET/CT: Positron Emission Tomography - Computed Tomography (PET/CT) |
Period Title: Overall Study | |
Started | 34 |
Completed | 34 |
Not Completed | 0 |
Baseline Characteristics
Arm/Group Title | 18F-DCFPyL PET/CT | |
---|---|---|
![]() |
Men and women of all races and ethnic groups are eligible for this study were encouraged to participate. | |
Overall Number of Baseline Participants | 34 | |
![]() |
[Not Specified]
|
|
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 34 participants | |
<=18 years |
0 0.0%
|
|
Between 18 and 65 years |
9 26.5%
|
|
>=65 years |
25 73.5%
|
|
Age, Continuous
Median (Full Range) Unit of measure: Years |
||
Number Analyzed | 34 participants | |
60
(18 to 76)
|
||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 34 participants | |
Female |
10 29.4%
|
|
Male |
24 70.6%
|
|
Ethnicity (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 34 participants | |
Hispanic or Latino |
1 2.9%
|
|
Not Hispanic or Latino |
31 91.2%
|
|
Unknown or Not Reported |
2 5.9%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||
Number Analyzed | 34 participants | |
American Indian or Alaska Native |
0 0.0%
|
|
Asian |
1 2.9%
|
|
Native Hawaiian or Other Pacific Islander |
0 0.0%
|
|
Black or African American |
0 0.0%
|
|
White |
31 91.2%
|
|
More than one race |
0 0.0%
|
|
Unknown or Not Reported |
2 5.9%
|
|
Region of Enrollment
Measure Type: Count of Participants Unit of measure: Participants |
||
United States | Number Analyzed | 34 participants |
34 100.0%
|
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Mohamad Allaf, MD |
Organization: | Johns Hopkins University |
Phone: | 410-502-7710 |
EMail: | mallaf@jhmi.edu |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Johns Hopkins University |
ClinicalTrials.gov Identifier: | NCT02687139 |
Other Study ID Numbers: |
IRB00075596 |
First Submitted: | February 11, 2016 |
First Posted: | February 22, 2016 |
Results First Submitted: | April 17, 2020 |
Results First Posted: | April 29, 2020 |
Last Update Posted: | April 29, 2020 |